ArticleNature communications2026
Distinct Filament Conformation for Receptor-Bound Amyloid-β from Alzheimer's Disease Brain.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
8 authors.
Funding
Abstract
Alzheimer's disease is triggered by amyloid-β, with symptoms linked to synapse loss. Oligomeric amyloid-β, rather than monomeric or fibrillar amyloid-β, has been proposed to be the proximate mechanistic cause, but the relevant molecular characteristics have remained unclear. To define the biologically relevant species, we isolated a receptor-bound amyloid-β pool from Alzheimer's disease brain by release with a receptor antagonist and purification to homogeneity. This discrete receptor-bound amyloid-β pool is ten times more abundant than free unbound amyloid-β and is comprised of 65 nm long filaments. The tips of these short filaments bind to prion protein and drive synapse loss from human neurons. Cryo-electron microscopy shows that the receptor-bound amyloid-β consists of two symmetric S-shaped amyloid-β monomers per filament rung. The overall structure is similar to much longer plaque-associated amyloid-β filaments from the same brain and fails to reveal an unrelated "oligomeric" conformation. Nonetheless, the receptor-bound amyloid-β can be distinguished from plaque filaments by the tilt angle of repeating amyloid-β subunits within each filament rung, by amino terminal conformation, by length and by amyloid seeding properties. Characterizing receptor-bound amyloid-β provides insight into neuronal dysfunction separate from plaque aggregation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.